Novel Role for Interleukin-2 Receptor-Jak Signaling in Retrovirus TransmissionTAYLOR, J. M; BROWN, M; NEJMEDDINE, M et al.Journal of virology. 2009, Vol 83, Num 22, pp 11467-11476, issn 0022-538X, 10 p.Article

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expressionDUNN, Gain P; SHEEHAN, Kathleen C. F; OLD, Lloyd J et al.Cancer research (Baltimore). 2005, Vol 65, Num 8, pp 3447-3453, issn 0008-5472, 7 p.Article

Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480HONG XIN; HERRMANN, Andreas; MOROSINI, Deborah et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 21, pp 6601-6610, issn 0008-5472, 10 p.Article

Dual Mechanism of Impairment of Interleukin-7 (IL-7) Responses in Human Immunodeficiency Virus Infection: Decreased IL-7 Binding and Abnormal Activation of the JAK/STAT5 PathwayJUFFROY, Olivier; BUGAULT, Florence; LAMBOTTE, Olivier et al.Journal of virology. 2010, Vol 84, Num 1, pp 96-108, issn 0022-538X, 13 p.Article

The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid LeukemiaLEE, Hun Ju; DAVER, Naval; KANTARJIAN, Hagop M et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 327-335, issn 1078-0432, 9 p.Article

The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-β-induced inhibitory signalingLEE, Youngkyun; HYUNG, Seok-Won; HEE JUNG JUNG et al.Blood. 2008, Vol 111, Num 2, pp 885-893, issn 0006-4971, 9 p.Article

Molecular Pathways: Molecular Basis for Sensitivity and Resistance to JAK Kinase InhibitorsMEYER, Sara C; LEVINE, Ross L.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2051-2059, issn 1078-0432, 9 p.Article

The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compoundsKAO, Kenneth K; FINK, Mitchell P.Biochemical pharmacology. 2010, Vol 80, Num 2, pp 151-159, issn 0006-2952, 9 p.Article

Metabolism, Excretion, and Pharmacokinetics of [¹⁴C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in HumansSHILLING, Adam D; NEDZA, Frank M; SHEPARD, Stacey et al.Drug metabolism and disposition. 2010, Vol 38, Num 11, pp 2023-2031, issn 0090-9556, 9 p.Article

Suppression of IL-1β expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cellsJI HOON YU; KYUNG HWAN KIM; KIM, Hyeyoung et al.Biochemical pharmacology. 2006, Vol 72, Num 11, pp 1555-1562, issn 0006-2952, 8 p.Article

A Kaposi's Sarcoma-Associated Herpesvirus Protein That Forms Inhibitory Complexes with Type I Interferon Receptor Subunits, Jak and STAT Proteins, and Blocks Interferon-Mediated Signal TransductionBISSON, Sabine A; PAGE, Anne-Laure; GANEM, Don et al.Journal of virology. 2009, Vol 83, Num 10, pp 5056-5066, issn 0022-538X, 11 p.Article

Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathwaySAGAWA, Morihiko; NAKAZATO, Tomonori; UCHIDA, Hideo et al.Cancer science. 2008, Vol 99, Num 9, pp 1820-1826, issn 1347-9032, 7 p.Article

The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2^V617F mutationMANSHOURI, Taghi; QUINTKS-CARDAMA, Alfonso; NUSSENZVEIG, Roberto H et al.Cancer science. 2008, Vol 99, Num 6, pp 1265-1273, issn 1347-9032, 9 p.Article

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the jak-STAT pathway and the mitogen-activated protein kinasesZHANGLE ZHOU; HAMMING, Ole J; ANK, Nina et al.Journal of virology. 2007, Vol 81, Num 14, pp 7749-7758, issn 0022-538X, 10 p.Article

Les récepteurs de cytokines = Cytokines' receptorGISSELBRECHT, Sylvie.Hématologie (Montrouge). 2003, Vol 9, Num 6, pp 477-483, issn 1264-7527, 7 p.Article

JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2^V617F-Driven DiseaseEVROT, Emeline; EBEL, Nicolas; HOFMANN, Francesco et al.Clinical cancer research (Print). 2013, Vol 19, Num 22, pp 6230-6241, issn 1078-0432, 12 p.Article

Immunotherapy for De Novo renal transplantation : What's in the pipeline?TEDESCO SILVA, Helio; PINHEIRO MACHADO, Paula; ROSSO FELIPE, Claudia et al.Drugs (Basel). 2006, Vol 66, Num 13, pp 1665-1684, issn 0012-6667, 20 p.Article

JAK inhibitors AG-490 and WHI-P154 decrease IFN-γ-Induced iNOS expression and NO production in macrophagesSAREILA, Outi; KORHONEN, Riku; KÄRPÄNNIEMI, Outi et al.Mediators of inflammation. 2006, Vol 2006, Num 2, pp 1-7, issn 0962-9351, 7 p.Article

STAT3-independent inhibition of lysophosphatidic acid-mediated upregulation of connective tissue growth factor (CTGF) by cucurbitacin IGRANESS, Angela; POLI, Valeria; GOPPELT-STRUEBE, Margarete et al.Biochemical pharmacology. 2006, Vol 72, Num 1, pp 32-41, issn 0006-2952, 10 p.Article

The role of Janus kinases in haemopoiesis and haematological malignancyKHWAJA, Asim.British journal of haematology. 2006, Vol 134, Num 4, pp 366-384, issn 0007-1048, 19 p.Article

The Effect of the JAK Inhibitor CP-690,550 on Peripheral Immune Parameters in Stable Kidney Allograft PatientsVAN GURP, Evelien A. F. J; SCHOORDIJK-VERSCHOOR, Wenda; KLEPPER, Mariska et al.Transplantation. 2009, Vol 87, Num 1, pp 79-86, issn 0041-1337, 8 p.Article

Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndromeKLUSMANN, J. H; REINHARDT, D; HASLE, H et al.Leukemia. 2007, Vol 21, Num 7, pp 1584-1587, issn 0887-6924, 4 p.Article

A gmcsf and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complexRAFEI, Moutih; JIAN HUI WU; ANNABI, Borhane et al.Blood. 2007, Vol 109, Num 5, pp 2234-2242, issn 0006-4971, 9 p.Article

Signal transducer and activator of transcription signals in allergic diseaseWEIGUO CHEN; KHURANA HERSHEY, Gurjit K.Journal of allergy and clinical immunology. 2007, Vol 119, Num 3, pp 529-541, issn 0091-6749, 13 p.Article

The c-Jun N-terminal kinase pathway and apoptotic signalingCHEN, Y.-R; TAN, T.-H.International journal of oncology. 2000, Vol 16, Num 4, pp 651-662, issn 1019-6439Article